Lexicon Pharmaceuticals, Inc. (LXRX)
1.69
-0.03
(-1.74%)
USD |
NASDAQ |
Mar 13, 16:00
1.67
-0.02
(-1.18%)
After-Hours: 20:00
Lexicon Pharmaceuticals Shareholders Equity (Quarterly) : 107.54M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viemed Healthcare, Inc. | 141.54M |
| ANI Pharmaceuticals, Inc. | 540.72M |
| Novavax, Inc. | -127.75M |
| Kura Oncology, Inc. | 174.14M |
| Liquidia Corp. | 44.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 184.99M |
| Total Liabilities (Quarterly) | 77.45M |
| Debt to Equity Ratio | 0.5787 |
| Current Ratio | 4.883 |
| Net Debt Paydown Yield | 2.09% |